Ayako Okuyama

Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Prognosis of Penile Squamous Cell Carcinoma and Extramammary Paget Disease in Japan: An Analysis of Nationwide Hospital-Based Cancer Registry Data.

Prognosis of Penile Squamous Cell Carcinoma and Extramammary Paget Disease in Japan: An Analysis of Nationwide Hospital-Based Cancer Registry Data.

Journal: Cancers

Published: June 01, 2026

Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening.

Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening.

Journal: JAMA oncology

Published: April 30, 2026

Evidence and Dissemination of Lively 100-Year-Old Exercise: Promoting Community-based Initiatives for Fall Prevention Among Community-dwelling Older Adults

Evidence and Dissemination of Lively 100-Year-Old Exercise: Promoting Community-based Initiatives for Fall Prevention Among Community-dwelling Older Adults

Journal: Nihon eiseigaku zasshi. Japanese journal of hygiene

Published: April 12, 2026

Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.

Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.

Journal: International journal of clinical oncology

Published: April 12, 2026

Developing quality indicators for supportive care in cancer treatment: a modified Delphi method.

Developing quality indicators for supportive care in cancer treatment: a modified Delphi method.

Journal: Japanese journal of clinical oncology

Published: February 26, 2026

Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy.

Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy.

Journal: International journal of clinical oncology

Published: May 29, 2025

Quality indicators of supportive care for patients with cancer undergoing treatment: a systematic review.

Quality indicators of supportive care for patients with cancer undergoing treatment: a systematic review.

Journal: BMC cancer

Published: November 26, 2024

Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.

Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: September 25, 2024

Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in Japan.

Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in Japan.

Journal: BMC cancer

Published: September 24, 2024

Authors' Response to Letter to Editor from Rongrui Zhao, Xinyue Ma, and Jiacui Zhang.

Authors' Response to Letter to Editor from Rongrui Zhao, Xinyue Ma, and Jiacui Zhang.

Journal: Annals of surgical oncology

Published: September 16, 2024

Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: August 01, 2024

Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: July 26, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026